clinical trails, conflicts of interest

"if professional societies and medical institutions do not demonstrate vigorous self- regulation and a commitment to keeping patients interests paramount, public trust may diminish, and more external regulation may be imposed" (Bernard Lo)

"Particularly attention must be paid when researchers offer some medical benefit that can be integrated easily into a course of treatment. Although subjects in these trials are offered a treatment of unproven efficacy, many mistakenly believe that they are receiving cutting-edge treatment guaranteed to improve their condition. This therapeutic misconception may be reinforced when subjects receive the experimental treatment from the same physician who has administered all of their care in the past, in contrast to being referred to a clinical investigator located in an academic setting with a reputation for conducting research" (Karine Morine, et al)

• Article (*.pdf): Managing conflicts of interest in the conduct of clinical trials (2002)
• Article (*.pdf): The future of conflicts of interest: A call for professional standards (2012)

photo: (*) Photosolde
_____________________________________________________________________